In this context however, it is worth mentioning that a recent study has indeed demonstrated that sorafenib resistance can be conferred through decreased KEAP1 protein expression leading to increased Nrf2 activity in HCC cell lines distinct from HUH-7 cells [32]. Here, KEAP1 is linked to hepatocellular carcinoma.